SavedAdd your journal

Journals / Çocuk Dergisi / 2005 / Cilt: 5 - Sayı: 2

Kawasaki disease

Kawasaki hastalığı

Nevin HATİPOĞLU
Nuran SALMAN
Pages
96–101
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Sequela in coronary arteries are thought to have a significant role in ischemic heart disease in young adults.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Kawasaki disease is an acute, febrile vasculitis of young pediatric age with unknown etiology.
📊
Key Findings & Data:Diagnostic criteria for Kawasaki disease are as follows: Fever for at least five days, generalized polymorphous erythematous rash, conjunctival injection, typical changes in the lips and oral cavity, erythema and swelling of hands and feet and unilateral nonfluctuating cervical lymphadenopathy >1.5 cm in diameter.
💡
Conclusion & Impact:Sequela in coronary arteries are thought to have a significant role in ischemic heart disease in young adults.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Vaskülit · Koroner anevrizma · Mukokutanöz lenf düğümü sendromu

Abstract

Kawasaki disease is an acute, febrile vasculitis of young pediatric age with unknown etiology. The diagnosis is based primarily on clinical features. Aneurysmatic changes and thromboses of coronary arteries are serious complications of the disease. Diagnostic criteria for Kawasaki disease are as follows: Fever for at least five days, generalized polymorphous erythematous rash, conjunctival injection, typical changes in the lips and oral cavity, erythema and swelling of hands and feet and unilateral nonfluctuating cervical lymphadenopathy >1.5 cm in diameter. Incomplete (atypical) Kawasaki disease can be considered in cases which does not have four of five criteria. The clinical course of the disease can be divided into acute, subacute and convalescent phases. Acute phase reactants are increased nonspecifically. Inflammatory infiltration (mononuclear cells, CD 8+ T lymphocytes and immunoglobulin A plasma cells) around the affected vessel can be detected. Any damage to coronary arteries should be sought using echocardiography as soon as the diagnosis is ascertained. Single use of intravenous immunglobulin (IVIG) 2 g/kg over 10-12 hours and acetyl salicylic acid 100 mg/kg/day usually is sufficient. It is controversial to give IVIG after 10 days. Pulse steroid can be used if there is resistance to IVIG therapy. The effectiveness and safety of treatment with immunosuppressive agents remain undetermined. Prognosis depends on the severity of the coronary artery disease. Myocardial infarction is the most frequent cause of mortality in Kawasaki disease. Coronary damage could have a role in the development of premature and serious atherosclerosis. Sequela in coronary arteries are thought to have a significant role in ischemic heart disease in young adults.

Özet

Kawasaki hastalığı çocukluk döneminin etiyolojisi belli olmayan akut, febril bir vaskülitidir. Tanı klinik bulgulara dayanılarak konur. Koroner arterlerde anevrizma gelişimi ve tromboz hastalığın ciddi komplikasyonlarıdır. Tanı için gerekli kriterler şunlardır: En az beş gündür yüksek ateş, generalize polimorf eritematöz döküntü, konjunktivalarda enjeksiyon, ağız ve dudaklarda tipik değişklikler, el ve ayaklarda bilateral şişlik ve kızarıklık ve tek taraflı fluktuasyon vermeyen > 1.5 cm. servikal lenfadenomegali. Ateş dışındaki beş kriterden dördünün birlikte olmadığı hallerde inkomplet (atipik) Kawasaki tanısı söz konusu olabilir. Hastalık akut, subakut ve konvalesan dönemlerden oluşur. Akut faz reaktanlarında nonspesifik artış vardır. Etkilenen damar etrafında inflamatuar infiltrasyon (mononükleer hücreler, CD 8+ T lenfositler ve immunglobülin A plazma hücreleri) görülür. Tanı konur konmaz, ekokardiyografi yapılarak koroner arterlerde hasar varlığı araştrılmalıdır. Tedavi için 2 g/kg tek doz intravenöz immunglobülin (İVİG) ve 80-100 mg/kg/gün asetil salisilik asit başlanmalıdır. Onuncu günden sonra İVİG verilmesinin yararı tartışmalıdır. İVİG ile yanıt alınamazsa pulse steroid denenebilir. İmmunsüpresif tedavinin etkinliği ve güvenirliği belirsizdir. Koroner arterlerin etkilenme durumu ve derecesine göre prognoz değişkenlik gösterir. Miyokard infarktüsü Kawasaki hastalığındaki en sık ölüm nedenidir. Koroner hasar, prematür ve ciddi ateroskleroz gelişiminde rol oynayabilir. Kawasaki hastalığında koroner arterlerdeki sekeller, genç erişkinlerde iskemik kalp hastalığının önemli bir nedeni olabilir.

🔖

Cite This Article

HATİPOĞLU, N., SALMAN, N. (2005). Kawasaki disease. Çocuk Dergisi, Cilt: 5 - Sayı: 2, 96–101. https://ajindex.com/articles/186011

References (14)

  1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jpn J Allerg 1967; 16: 178-222.
  2. Taubert KA, Rowley AH, Shulman ST. A 10-year (1984-1993) United States hospital survey of Kawasaki disease. In: Kato H, ed. Kawasaki Disease. Amsterdam: Elsevier Science, 1995:34-8.
  3. Yanagawa H, Nakamura Y, Yashiro M, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics 1998; 102:E65. Nakamura Y, Yanagawa H, Harada K, Kato H, Kawasaki T. Mortality among persons with a history of Kawasaki disease in Japan: The fifth look. Arch Pediatr Adolesc Med 2002; 156: 162-5.
  4. Momenah T, Sanatani S, Potts J, et al. Kawasaki disease in the older child. Pediatrics 1998; 102: e7. Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr 2000; 137: 250-2.
  5. Milgrom H, Palmer EL, Slovin SF, Morens DM, Freedman SD, Vaughan JH. Kawasaki disease in healthy young adult. Ann Intern Med 1980; 92:467-70.
  6. Hayasaka S, Nakamura Y, Yashiro M, et al. Analyses of fatal cases of Kawasaki disease in Japan using vital statistical data over 27 years. J Epidemiol 2003; 13: 246-50.
  7. Nakamura Y, Hirose K, Yanagawa H, Kato H, Kawasaki T. Incidence rate of recurrent Kawasaki disease in Japan. Acta Paediatr 1994; 83: 1061-4.
  8. Rowley AH, Wolinsky SM, Relman DA, et al. Search for highly conserved viral and bacterial nucleic acid sequences corres­ ponding to an etiologic agent of Kawasaki disease. Pediatr Res 1994; 36: 567-71.
  9. Landing BH, Larson EJ. Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan. Pediatrics 1977; 59: 651-62.
  10. Tanaka N, Sekimoto K, Naoe S. Kawasaki disease. Relati­ onship with infantile periarteritis nodosa. Arch Pathol Lab Med 1976; 100:81-6.
  11. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978; 61: 100-7.
  12. Fujiwara H, Fujiwara T, Kao TC, Ohshio G, Hamashima Y. Pathology of Kawasaki disease in the healed stage. Relations­ hips between typical and atypical cases of Kawasaki disease. Acta Pathol Jpn 1986; 36: 857-67.
  13. Hicks RV, Melish ME. Kawasaki syndrome. Pediatr Clin North Am 1986; 33: 1151-75.
  14. Uehara R, Yashiro M, Hayasaka S, et al. Serum alanine aminotransferase concentrations in patients with Kawasaki disease. Pediatr Infect Dis J 20